Cargando…

Assessing Palatability of a New Amphetamine Extended-Release Tablet Formulation for the Treatment of ADHD

INTRODUCTION/OBJECTIVE: ADHD is, for many people, a lifelong disease that requires chronic medication use. Stimulant therapy is often recommended as first-line treatment for ADHD. Adherence to stimulant treatment among patients diagnosed with ADHD is poor. Major regulatory agencies have recommended...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pardo, Antonio, King, Thomas R, Rafla, Eman, Kando, Judith C
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8275141/ https://www.ncbi.nlm.nih.gov/pubmed/34262263 http://dx.doi.org/10.2147/DDDT.S309378

Ejemplares similares

Efficacy of Amphetamine Extended-Release Oral Suspension in Children with Attention-Deficit/Hyperactivity Disorder: Effect Size Across the Day
por: Faraone, Stephen V., et al.
Publicado: (2023)

Early-Onset Efficacy and Safety Pilot Study of Amphetamine Extended-Release Oral Suspension in the Treatment of Children with Attention-Deficit/Hyperactivity Disorder
por: Childress, Ann C., et al.
Publicado: (2019)

Formulation Development and Stability Studies of Norfloxacin Extended-Release Matrix Tablets
por: Oliveira, Paulo Renato, et al.
Publicado: (2013)

Development of In Vitro–In Vivo Correlation for Upadacitinib Extended-Release Tablet Formulation
por: Mohamed, Mohamed-Eslam F., et al.
Publicado: (2019)

Formulation and Evaluation of Trimetazidine Dihydrochloride Extended Release Tablets by Melt Congealing Method
por: Javeer, S. D., et al.
Publicado: (2010)

Formulation and Evaluation of Once Daily Minocycline Hydrochloride Extended Release Matrix Tablets
por: Keny, R. V., et al.
Publicado: (2009)

Formulation and in vitro Evaluation of Alfuzosin Extended Release Tablets Using Directly Compressible Eudragit
por: Roni, M. A., et al.
Publicado: (2009)

The Palatability of Lopinavir and Ritonavir Delivered by an Innovative Freeze-Dried Fast-Dissolving Tablet Formulation
por: Pittman, David W., et al.
Publicado: (2018)

Efficacy, Safety, and Palatability of RACTAB® Formulation Amlodipine Orally Disintegrating Tablets
por: Fukui-Soubou, Mari, et al.
Publicado: (2012)

Formulation and Evaluation of Cephalexin Extended Release Matrix Tablets Using 3(2) Factorial Design
por: Jishnu, V, et al.
Publicado: (2011)

Design and evaluation of an extended-release matrix tablet formulation; the combination of hypromellose acetate succinate and hydroxypropylcellulose
por: Fukui, Sachiko, et al.
Publicado: (2017)

Effects of Food on the Bioavailability of Amphetamine in Healthy Adults After Administration of SHP465 Mixed Amphetamine Salts Extended-Release Capsules
por: Wang, Yi, et al.
Publicado: (2019)

Assessment of Alcohol-Induced Dose Dumping with a Hydrocodone Bitartrate Extended-Release Tablet Formulated with CIMA(®) Abuse Deterrence Technology
por: Darwish, Mona, et al.
Publicado: (2015)

Additive Manufacturing of an Extended-Release Tablet of Tacrolimus
por: Abdollahi, Azin, et al.
Publicado: (2023)

Optimization of Methylphenidate Extended-Release Chewable Tablet Dose in Children with ADHD: Open-Label Dose Optimization in a Laboratory Classroom Study
por: Wigal, Sharon B., et al.
Publicado: (2018)

Surveillance of Diversion and Nonmedical Use of Extended-Release Prescription Amphetamine and Oral Methylphenidate in the United States
por: Sembower, Mark A., et al.
Publicado: (2013)

Efficacy and Safety of Amphetamine Extended-Release Oral Suspension in Children with Attention-Deficit/Hyperactivity Disorder
por: Childress, Ann C., et al.
Publicado: (2018)

Metoprolol succinate extended release/hydrochlorothiazide combination tablets
por: Hainer, James W, et al.
Publicado: (2007)

Formulation and Evaluation of Cephalexin Extended-release Matrix Tablets Using Hydroxy Propyl Methyl Cellulose as Rate-controlling Polymer
por: Vijay, J, et al.
Publicado: (2012)

Formulation, evaluation and optimization of sustained release matrix tablets of captopril
por: Pandya, V. Pandya, et al.
Publicado: (2012)

Formulation and evaluation of bilayer tablet for bimodal release of venlafaxine hydrochloride
por: Momin, Munira M., et al.
Publicado: (2015)

The Effect of Humidity on the Dissolution Kinetics and Tablet Properties of Immediate-Release Tablet Formulation Containing Lamotrigine
por: Lalić-Popović, Mladena, et al.
Publicado: (2022)

Useful Extend-release Chitosan Tablets with High Antioxidant Activity
por: Yasufuku, Taira, et al.
Publicado: (2010)

Development and bioequivalence study of potassium chloride extended release tablets
por: Le Thi, Thu Van, et al.
Publicado: (2018)

Development of Biopredictive Dissolution Method for Extended-Release Desvenlafaxine Tablets
por: Carapeto, Gustavo Vaiano, et al.
Publicado: (2023)

A new extended release formulation (OROS(®)) of hydromorphone in the management of pain
por: Weinstein, Sharon M
Publicado: (2009)

Fed and fasted bioequivalence assessment of two formulations of extended-release fixed-dose combination dapagliflozin/metformin (10/1,000 mg) tablets in healthy subjects
por: Lee, Hae Won, et al.
Publicado: (2023)

Effect of Hydrophilic Diluents on the Release Profile of Griseofulvin from Tablet Formulations
por: Umeh, O. N. C., et al.
Publicado: (2013)

Formulation and Evaluation of New Glimepiride Sublingual Tablets
por: Al-Madhagi, Wafa, et al.
Publicado: (2017)

Clinical utility of guanfacine extended release in the treatment of ADHD in children and adolescents
por: Bello, Nicholas T
Publicado: (2015)

A kinetic account for amphetamine-induced monoamine release
por: Hasenhuetl, Peter S., et al.
Publicado: (2018)

Formulation and Evaluation of Hydroxypropyl Methylcellulose-based Controlled Release Matrix Tablets for Theophylline
por: Sekharan, T. Raja, et al.
Publicado: (2011)

Formulation and Evaluation of Controlled-Release Tablet of Zolpidem Tartrate by Melt Granulation Technique
por: Prajapati, Shailesh T., et al.
Publicado: (2011)

Evaluation of Gum of Moringa oleifera as a Binder and Release Retardant in Tablet Formulation
por: Panda, D. S., et al.
Publicado: (2008)

Pharmacokinetics and Pharmacodynamics of Gliclazide from Immediate and Modified Release Formulation Tablets in Rats
por: Resztak, M, et al.
Publicado: (2014)

The Effect of Formulation Excipients and Thermal Treatment on the Release Properties of Lisinopril Spheres and Tablets
por: Amador Ríos, Zoriely, et al.
Publicado: (2015)

Chitosan-Montmorillonite Polymer Composites: Formulation and Evaluation of Sustained Release Tablets of Aceclofenac
por: Thakur, Garima, et al.
Publicado: (2015)

Investigation of the potential application of sodium bentonite as an excipient in formulation of sustained release tablets
por: Alkrad, Jamal Alyoussef, et al.
Publicado: (2017)

Formulation of Modified-Release Bilayer Tablets of Atorvastatin and Ezetimibe: An In-Vitro and In-Vivo Analysis
por: Mubeen, Iqra, et al.
Publicado: (2022)

Biorelevant In Vitro Release Testing and In Vivo Study of Extended-Release Niacin Hydrophilic Matrix Tablets
por: Milanowski, Bartłomiej, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_hln9icqlk00t9ovns8fg9oge8h